Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Oct 24, 2021; 12(10): 960-965
Published online Oct 24, 2021. doi: 10.5306/wjco.v12.i10.960
Published online Oct 24, 2021. doi: 10.5306/wjco.v12.i10.960
Gastric myeloid sarcoma: A case report
Patricia Rioja, Jackeline Macetas, Department of Oncology Medicine, Instituto Nacional de Enfermedades Neoplásicas, Lima 15000, Peru
Jorge Luna-Abanto, Department of Surgical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima 15000, Peru
Indira Tirado-Hurtado, Universidad Privada San Juan Bautista, Filial Chincha 11702, Peru
Daniel J Enriquez, Universidad Privada San Juan Bautista, Lima 15000, Peru
Author contributions: Rioja P, Macetas J and Enriquez DJ participated in the clinical management of the patient, the conception of the case report, and writing; Tirado-Hurtado I and Luna-Abanto J participated with the writing and critical review of the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this manuscript, also the accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jorge Luna-Abanto, MD, Surgical Oncologist, Department of Oncological Surgery, Instituto Nacional de Enfermedades Neoplásicas, Av. Angamos Este 2520, Lima 15000, Peru. jorgelunaabanto@gmail.com
Received: April 21, 2021
Peer-review started: April 21, 2021
First decision: July 16, 2021
Revised: July 26, 2021
Accepted: September 19, 2021
Article in press: September 19, 2021
Published online: October 24, 2021
Processing time: 183 Days and 14.1 Hours
Peer-review started: April 21, 2021
First decision: July 16, 2021
Revised: July 26, 2021
Accepted: September 19, 2021
Article in press: September 19, 2021
Published online: October 24, 2021
Processing time: 183 Days and 14.1 Hours
Core Tip
Core Tip: This case report describes a gastric primary de novo myeloid sarcoma (MS) which is a very rare hematological neoplasm with poor prognosis in a young and symptomatic patient. After receiving chemotherapy, she presented severe toxicity (neutropenic typhlitis) and rapid disease progression. This case highlights the importance of detecting gastric primary MS as a rare form of extramedullary myeloid leukemia presentation. Moreover, management of gastric primary MS could lead to interventions to avoid deterioration of gastrointestinal system during treatment. There is limited information of management and outcomes regarding gastric primary MS. Furthermore, there is very limited data about de novo MS in Peruvian patients.